<?xml version="1.0" encoding="iso-8859-1" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Pharmalicensing.com: Industry news</title>
		<link>http://pharmalicensing.com/rss/</link>
		<description>Latest market and business intelligence from the leading publishers worldwide.</description>
		<language>en-us</language>
		<image>
			<title>Pharmalicensing.com: Industry news</title>
			<link>http://pharmalicensing.com/rss/</link>
			<url>http://pharmalicensing.com/images/pharmalicensing_logo.gif</url>
			<width>144</width>
		</image>
							<item>
				<title>Nufarm acquires DuPont cotton portfolio</title>
				<description>June 18, 2008 - Nufarm Ltd announced today it has completed the acquisition of a range of cotton plant growth regulator (PGR) products from DuPont</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/426996/1</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/426996/1</guid>
			</item>
				<item>
				<title>AMRI to Receive Second Milestone Payment From Licensing Agreement with Bristol-Myers Squibb</title>
				<description>Albany, NY (June 12, 2008) - AMRI (NASDAQ: AMRI) announced today it will receive a $4 million milestone payment from Bristol-Myers Squibb Company (NYSE: BMY) as a result of Bristol-Myers Squibb&amp;#039;s...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/425919/1</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/425919/1</guid>
			</item>
				<item>
				<title>Finnish Red Cross Blood Service Licenses Ariadne Pathway Studio Enterprise</title>
				<description>ROCKVILLE, MD, June 18, 2008 - Ariadne today announced that Finnish Red Cross has licensed Pathway Studio Enterprise for pathway, biological process and disease modeling. Finnish Red Cross scientists...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/427000/1</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/427000/1</guid>
			</item>
				<item>
				<title>Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial</title>
				<description>SOUTH SAN FRANCISCO, Calif., June 16, 2008 -- Exelixis, Inc. (Nasdaq: EXEL) announced today that the company and the U.S. Food and Drug Administration (FDA) have reached agreement on the phase 3...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/426659/1</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/426659/1</guid>
			</item>
				<item>
				<title>4SC to acquire Nycomed oncology projects</title>
				<description>Planegg-Martinsried, Germany, 04 June 2008 - Martinsried-based drug discovery and development company 4SC AG (Frankfurt, Prime Standard: VSC) today announced the signing of a contract to acquire...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/424205/1</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/424205/1</guid>
			</item>
					<atom:link href="http://pharmalicensing.com/public/rss/news/most_viewed/1" rel="self" type="application/rss+xml" />
	</channel>
</rss>
